| Identification | Back Directory | [Name]
1H-Pyrazole-1-propanoic acid, β-cyclopentyl-4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-, (βR)- | [CAS]
2102675-40-9 | [Synonyms]
1H-Pyrazole-1-propanoic acid, β-cyclopentyl-4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-, (βR)-
(R)-3-(4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)-3-cyclopentylpropanoic acid
(βR)?-β-?Cyclopentyl-?4-?(7H-?pyrrolo[2,?3-?d]?pyrimidin-?4-?yl)?-1H-?pyrazole-?1-?propanoic Acid | [Molecular Formula]
C17H19N5O2 | [MOL File]
2102675-40-9.mol | [Molecular Weight]
325.37 |
| Hazard Information | Back Directory | [Uses]
(βR)?-β-?Cyclopentyl-?4-?(7H-?pyrrolo[2,?3-?d]?pyrimidin-?4-?yl)?-1H-?pyrazole-?1-?propanoic Acid is a useful reagent for preparing Ruxolitinib (R702000(P)), which is a selective Janus tyrosine kinase (JAK1 and JAK2) inhibitor used in the treatment of myeloproliferative neoplasms and psoriasis. It is also a potent JAK2 inhibitor. |
|
| Company Name: |
Svak Life Sciences
|
| Tel: |
+91-9963463333 +91-9705383777 |
| Website: |
www.svaklifesciences.com |
|